Reuters
False Claims Act Liability: When Do Claims for Health Care Reimbursement 'Result From' Anti-Kickback Statute Violations?
September 25, 2025
The Department of Justice and Department of Health and Human Services recently renewed their False Claims Act (FCA) Working Group, reinforcing scrutiny of health care and life sciences companies, with a focus on Anti-Kickback Statute (AKS) violations. A circuit split has developed over whether FCA liability requires strict “but-for” causation between AKS violations and reimbursement claims, or only a looser “link.” Most circuits now favor the more stringent “but-for” standard, while the 3rd Circuit continues to apply the link test. As courts move toward the stricter view, DOJ and relators are increasingly relying on false certification theories to pursue FCA claims tied to AKS violations.
Contacts
Capabilities
Suggested News & Insights
TX AG’s Office Continues Aggressive Enforcement Against Healthcare Entities Operating in TexasFebruary 25, 2026DAAG Brenna Jenny Warns Heightened FCA Enforcement Is “The New Normal,” Addresses Enforcement Priorities and PoliciesFebruary 20, 2026DAAG Jenny Reinforces Commitment to FCA Enforcement Premised on “Unlawful DEI”February 20, 2026DOJ Attorneys Underscore Heightened Focus on Trade Fraud During the Annual Qui Tam ConferenceFebruary 19, 2026Drug Pricing and Medicaid Rebate Reporting: Enforcement Risk RemainsFebruary 17, 2026OIG Releases Long-Awaited Medicare Advantage Compliance Program GuidanceFebruary 10, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


